Skip to main content
Advanced Technical IVT

cytokine release syndrome

Systemic inflammatory response caused by immune activation from certain cancer treatments.

Full Definition

Cytokine release syndrome (CRS) is a systemic inflammatory response syndrome caused by widespread activation of immune cells, leading to massive release of cytokines. In oncology, CRS is most commonly associated with immunotherapies such as CAR-T cell therapy and some monoclonal antibodies. Symptoms range from mild flu-like illness to severe multi-organ dysfunction including high fever, hypotension, and respiratory distress. Management involves supportive care and anti-inflammatory medications such as tocilizumab. Early recognition and intervention are crucial for patient safety.

Usage

Usage note: Often abbreviated as CRS; distinguish from sepsis which has infectious etiology.

In Context

  • "The patient developed grade 2 cytokine release syndrome following CAR-T cell infusion." — Immunotherapy monitoring report
  • "Tocilizumab was administered to manage severe cytokine release syndrome symptoms." — Emergency treatment record

Also known as

CRS cytokine storm

Don't confuse with

tumor lysis syndrome sepsis

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON